Abstract:Key Points A large fraction of point mutations that cause genetic diseases affect splicing efficiency and/or accuracy. Most of these mutations directly affect the canonical consensus sequences that define exon–intron boundaries, and are therefore correctly identified as 'splicing mutations'. Information that is present in the coding regions of genes also contributes to the correct identification of exon–intron boundaries. For example, exonic splicing enhancer (ESE) and silencer (ESS) elements are very prevalent and might be present in most, if not all, constitutive and alternative exons. ESEs are recognized by a class of splicing factors, the SR proteins, that promote splicing by recruiting spliceosomal components to the correct splice sites and/or by antagonizing the action of nearby silencers. Several classes of ESEs, which are recognized by different SR proteins, have been identified, and computational tools are being developed to predict the location, specificity and efficiency of putative ESEs. Because ESEs are embedded in protein-coding sequences, some nonsense, missense and translationally silent point mutations have actually been misclassified. Those mutations that inactivate an ESE can result in partial or complete exon skipping, and can therefore markedly affect the structure or amounts of the expressed protein product. An increasing proportion of point mutations are being reported to affect pre-mRNA splicing. Although reading-frame-dependent mechanisms have been proposed to account for nonsense-associated altered splicing (NAS), in most cases the disruption of ESEs or of RNA secondary structures that are required for proper splicing seems to be the mechanism that leads to exon skipping, regardless of the type of point mutation. Some coding single-nucleotide polymorphisms (cSNPs) can be expected likewise to disrupt elements that are involved in splicing and to exert a subtle effect on splice-site selection, thereby contributing to phenotypic variability, to the variable penetrance of mutations elsewhere in the gene and to cell-type-specific differences in gene expression. The effects of point mutations should be routinely analysed at the mRNA level before drawing conclusions about the importance of the affected amino acid, as their correct classification in terms of the actual mechanism of gene inactivation is essential for understanding structure–function relationships in the corresponding protein, for assessing the phenotypic risk in individuals with familial disease predispositions and for devising new therapies.

Alteration of protein function by a silent polymorphism linked to tRNA abundance

Silent Mutations in Sight: Co-Variations in Trna Abundance As a Key to Unravel Consequences of Silent Mutations

Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy.

Silent SNPs: impact on gene function and phenotype

Bicodon bias can determine the role of synonymous SNPs in human diseases

A snoRNA-tRNA modification network governs codon-biased cellular states

Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support Non-translational Function.

Regsnps-Splicing: a Tool for Prioritizing Synonymous Single-Nucleotide Substitution

Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations

Listening to silence and understanding nonsense: exonic mutations that affect splicing

Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity

Increased expression of tryptophan and tyrosine tRNAs elevates stop codon readthrough of reporter systems in human cell lines

Polymorphisms Affecting Gene Transcription and Mrna Processing in Pharmacogenetic Candidate Genes: Detection Through Allelic Expression Imbalance in Human Target Tissues

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

Combined tRNA modification defects impair protein homeostasis and synthesis of the yeast prion protein Rnq1

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression

Computational Analysis of Functional Single Nucleotide Polymorphisms Associated with the CYP11B2 Gene

Alternate RNA decoding results in stable and abundant proteins in mammals

Mistranslation of the genetic code by a new family of bacterial transfer RNAs

Exploring the Structural and Functional Effects of Nonsynonymous SNPs in the Human Serotonin Transporter Gene Through In Silico Approaches

Mistranslating tRNA variants have anticodon- and sex-specific impacts on Drosophila melanogaster